EAGLE PHARMACEUTICALS INC (EGRX) Institutional Ownership and Insiders Activity

EAGLE PHARMACEUTICALS INC (EGRX) is widely held by institutional investors, with 2 firms reporting positions valued at approximately $8,275 based on SEC Form 13F filings for the quarter ended June 30, 2026.

Stanley-Laman Group, Ltd. is the largest disclosed holder, reporting approximately $8,040 in EGRX holdings in its latest filing.

Institutional ownership remains highly concentrated, with Stanley-Laman Group, Ltd. representing the majority of disclosed value.